Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,126 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Multi-Center Study of Sensory Stimulation to Improve Brain Function

NCT03556280

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +26 more
Locations
  • Brain Matters Research Delray Beach, Florida, United States
  • Brain Matters Research Stuart, Florida, United States
  • ActivMed Practices & Research, Inc Methuen, Massachusetts, United States
  • Boston Center for Memory Newton, Massachusetts, United States
View Trial Details
Active, not recruiting

An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients

NCT03606577

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHU de Nantes Nantes, Pays de la Loire Region, France
  • CHU Caen Caen, France
  • CHRU Dijon Dijon, France
  • CHRU - Hôpital A.Michallon Grenoble, France
View Trial Details
Completed

Imaging Young Myeloma (IMAgerie JEune Myélome)

NCT01309334

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Bordeaux University Hospital Bordeaux, France
  • Brest University Hospital "CHU du Morvan" Brest, France
  • Hospital "Côte de Nacre" Caen, France
  • Clermont-Ferrand University Hospital Clermont-Ferrand, France
View all 17 locations
View Trial Details
Completed

Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

NCT01971658

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Centre Hospitalier de la région d'Annecy Annecy, Pringy, France
  • CHRU Hôpital Sud Amiens, France
  • Centre Hospitalier Argenteuil Argenteuil, France
  • Centre Hospitalier H.Duffaut Avignon, France
View all 62 locations
View Trial Details
Completed

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

NCT01936532

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • CHRU - Hôpital du Haut Lévêque Bordeaux, France
  • CHRU Dijon Dijon, France
  • Centre hospitalier départemental Vendée La Roche-sur-Yon, France
  • CHRU - Hôpital Claude Huriez Lille, France
View Trial Details

Related conditions